Yuko Hirata

1.3k total citations
64 papers, 967 citations indexed

About

Yuko Hirata is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, Yuko Hirata has authored 64 papers receiving a total of 967 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Psychiatry and Mental health, 16 papers in Pediatrics, Perinatology and Child Health and 12 papers in Molecular Biology. Recurrent topics in Yuko Hirata's work include Epilepsy research and treatment (24 papers), Pharmacological Effects and Toxicity Studies (14 papers) and Neuroscience and Neuropharmacology Research (8 papers). Yuko Hirata is often cited by papers focused on Epilepsy research and treatment (24 papers), Pharmacological Effects and Toxicity Studies (14 papers) and Neuroscience and Neuropharmacology Research (8 papers). Yuko Hirata collaborates with scholars based in Japan, Canada and United States. Yuko Hirata's co-authors include Masaaki Tokuda, Kazuyo Kamitori, Fuminori Yamaguchi, Youyi Dong, Li Sui, Ikuko Tsukamoto, Akram Hossain, Koichi Yamanishi, Ryuki Matsuura and Shin‐ichiro Hamano and has published in prestigious journals such as PLoS ONE, Journal of Virology and Biochemical and Biophysical Research Communications.

In The Last Decade

Yuko Hirata

59 papers receiving 952 citations

Peers

Yuko Hirata
Éva Kereszturi Hungary
Gili Solomon Israel
G. Fayet France
Gerard Honig United States
Paola Sacchetti United States
Hideaki Kondo Japan
D Caparros-Lefèbvre France
Shinobu Takayasu Japan
Thierry Lesté-Lasserre France
Paul Ordronneau United States
Éva Kereszturi Hungary
Yuko Hirata
Citations per year, relative to Yuko Hirata Yuko Hirata (= 1×) peers Éva Kereszturi

Countries citing papers authored by Yuko Hirata

Since Specialization
Citations

This map shows the geographic impact of Yuko Hirata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuko Hirata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuko Hirata more than expected).

Fields of papers citing papers by Yuko Hirata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuko Hirata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuko Hirata. The network helps show where Yuko Hirata may publish in the future.

Co-authorship network of co-authors of Yuko Hirata

This figure shows the co-authorship network connecting the top 25 collaborators of Yuko Hirata. A scholar is included among the top collaborators of Yuko Hirata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuko Hirata. Yuko Hirata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matsuura, Ryuki, Haruhito Horita, Yuko Hirata, et al.. (2024). Adrenocorticotropic hormone therapy alters Q-albumin ratios in patients with infantile epileptic spasms syndrome of unknown etiology. Journal of the Neurological Sciences. 465. 123187–123187. 2 indexed citations
2.
Matsuura, Ryuki, Shin‐ichiro Hamano, Yuko Hirata, et al.. (2023). Long-term analysis of adrenocorticotropic hormone monotherapy for infantile epileptic spasms syndrome with periventricular leukomalacia. Seizure. 109. 40–44. 6 indexed citations
3.
Kikuchi, Kenjiro, Yuko Hirata, Ryuki Matsuura, et al.. (2022). Efficacy of Anti-seizure Medications for Epilepsy after Autoimmune-mediated Encephalitis in Childhood. Journal of the Japan Epilepsy Society. 40(1). 2–9.
4.
Kikuchi, Kenjiro, Shin‐ichiro Hamano, Ryuki Matsuura, et al.. (2022). The effectiveness of intravenous benzodiazepine for status epilepticus in Dravet syndrome. Brain and Development. 44(5). 319–328. 1 indexed citations
5.
Matsuura, Ryuki, Shin‐ichiro Hamano, Jun Kubota, et al.. (2021). Serum matrix metallopeptidase-9 and tissue inhibitor of metalloproteinase-1 levels may predict response to adrenocorticotropic hormone therapy in patients with infantile spasms. Brain and Development. 44(2). 114–121. 6 indexed citations
6.
7.
Matsuura, Ryuki, Shin‐ichiro Hamano, Jun Kubota, et al.. (2019). Serum matrix metallopeptidase-9 and tissue inhibitor of metalloproteinase-1 levels in autoimmune encephalitis. Brain and Development. 42(3). 264–269. 2 indexed citations
8.
Matsuura, Ryuki, et al.. (2018). Elevated Serum MMP-9 and MMP/TIMP-1 Ratio in Patients with Migrainous Infarction and Hemiplegic Migraine. Journal of Neurology and Neuroscience. 9(6). 1 indexed citations
9.
Kamitori, Kazuyo, Fuminori Yamaguchi, Youyi Dong, et al.. (2018). Both Ser361 phosphorylation and the C‐arrestin domain of thioredoxin interacting protein are important for cell cycle blockade at the G1/S checkpoint. FEBS Open Bio. 8(11). 1804–1819. 13 indexed citations
10.
Hamano, Shin‐ichiro, et al.. (2018). Treatment of infantile spasms by pediatric neurologists in Japan. Brain and Development. 40(8). 685–692. 17 indexed citations
11.
12.
Hamano, Shin‐ichiro, et al.. (2018). Enhancement and bilateral synchronization of ripples in atypical benign epilepsy of childhood with centrotemporal spikes. Clinical Neurophysiology. 129(9). 1920–1925. 12 indexed citations
13.
14.
Lee, Soyoung Irene, Dong‐Ho Song, Dong Won Shin, et al.. (2014). Efficacy and safety of atomoxetine hydrochloride in Korean adults with attention-deficit hyperactivity disorder. Asia-Pacific Psychiatry. 6(4). 386–396. 13 indexed citations
15.
Hossain, Akram, Ikuko Tsukamoto, Fuminori Yamaguchi, et al.. (2014). Intestinal absorption, organ distribution, and urinary excretion of the rare sugar D-psicose. Drug Design Development and Therapy. 8. 1955–1955. 42 indexed citations
16.
Yamaguchi, Fuminori, Yuko Hirata, Akram Hossain, et al.. (2013). FOXO/TXNIP pathway is involved in the suppression of hepatocellular carcinoma growth by glutamate antagonist MK-801. BMC Cancer. 13(1). 468–468. 75 indexed citations
17.
Hirata, Yuko, Clement C. Zai, Renan P. Souza, et al.. (2012). Association study of GRIK1 gene polymorphisms in schizophrenia: case–control and family‐based studies. Human Psychopharmacology Clinical and Experimental. 27(4). 345–351. 14 indexed citations
18.
Kishi, Yoji, et al.. (2012). Rapid recovery of base station backhaul by the neighbor regional wireless access network and its extension with the multi-hop wireless LAN relay. Wireless Personal Multimedia Communications. 221–224. 4 indexed citations
19.
Hasan, Arif Ul, Koji Ohmori, Takeshi Hashimoto, et al.. (2011). Pioglitazone promotes preadipocyte proliferation by downregulating p16Ink4a. Biochemical and Biophysical Research Communications. 411(2). 375–380. 10 indexed citations
20.
Hirata, Yuko, et al.. (1997). A study for TUNEL assay as a method of detecting apoptotic cells.. The Journal of the Japanese Society of Clinical Cytology. 36(4). 349–357.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Éva Kereszturi Breakdown of academic impact, for papers by Gili Solomon Breakdown of academic impact, for papers by G. Fayet Breakdown of academic impact, for papers by Gerard Honig Breakdown of academic impact, for papers by Paola Sacchetti Breakdown of academic impact, for papers by Hideaki Kondo Breakdown of academic impact, for papers by D Caparros-Lefèbvre Breakdown of academic impact, for papers by Shinobu Takayasu Breakdown of academic impact, for papers by Thierry Lesté-Lasserre Breakdown of academic impact, for papers by Paul Ordronneau
Rankless by CCL
2026